Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Nov;3(6):756–760. doi: 10.1128/cdli.3.6.756-760.1996

Parvovirus B19 in anemic liver transplant recipients.

O K Ndimbie 1, E Frezza 1, J A Jordan 1, W Koch 1, D H van Thiel 1
PMCID: PMC170443  PMID: 8914771

Abstract

Five hundred thirty-three liver transplant recipients were seen for follow-up care over a 6-month period. Of these, 23 (4.3%) had a hemoglobin level of < or = 9 g/dl, with 19 being eligible for inclusion in this study. The median hemoglobin level was 8.7 g/dl. Two patients had iron-deficiency anemia. All of the patients were on therapeutic drugs which can suppress erythropoiesis or shorten the lifespan of mature erythrocytes. Six patients (31.6%) were viremic for human parvovirus B19 but none was B19 immunoglobulin M seropositive. Two patients were immunoglobulin M seropositive for cytomegalovirus. The patients with circulating B19 DNA were not easily distinguished from those without the virus by their laboratory results. The absence of reticulocyte counts for these patients contributed to this inability to differentiate B19 from other causes of anemia, particularly drug myelotoxicity. The high likelihood of making a specific diagnosis with the increasing availability of PCR should spur the search for this virus in the liver transplant population.

Full Text

The Full Text of this article is available as a PDF (184.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. J., Higgins P. G., Davis L. R., Willman J. S., Jones S. E., Kidd I. M., Pattison J. R., Tyrrell D. A. Experimental parvoviral infection in humans. J Infect Dis. 1985 Aug;152(2):257–265. doi: 10.1093/infdis/152.2.257. [DOI] [PubMed] [Google Scholar]
  2. Anderson M. J., Lewis E., Kidd I. M., Hall S. M., Cohen B. J. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 1984 Aug;93(1):85–93. doi: 10.1017/s0022172400060964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Azzi A., Ciappi S., Zakvrzewska K., Morfini M., Mariani G., Mannucci P. M. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol. 1992 Mar;39(3):228–230. doi: 10.1002/ajh.2830390315. [DOI] [PubMed] [Google Scholar]
  4. Bartolomei Corsi O., Azzi A., Morfini M., Fanci R., Rossi Ferrini P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol. 1988 Jun;25(2):165–170. doi: 10.1002/jmv.1890250206. [DOI] [PubMed] [Google Scholar]
  5. Brown K. E., Anderson S. M., Young N. S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993 Oct 1;262(5130):114–117. doi: 10.1126/science.8211117. [DOI] [PubMed] [Google Scholar]
  6. Brown T., Anand A., Ritchie L. D., Clewley J. P., Reid T. M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984 Nov 3;2(8410):1033–1034. doi: 10.1016/s0140-6736(84)91126-7. [DOI] [PubMed] [Google Scholar]
  7. Cattral M. S., Langnas A. N., Markin R. S., Antonson D. L., Heffron T. G., Fox I. J., Sorrell M. F., Shaw B. W., Jr Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology. 1994 Oct;20(4 Pt 1):813–818. doi: 10.1002/hep.1840200407. [DOI] [PubMed] [Google Scholar]
  8. Cooper DL. Introduction. Mol Diagn. 1996 Jun;1(1):1–3. doi: 10.1054/MODI00100001. [DOI] [PubMed] [Google Scholar]
  9. Cossart Y. E., Field A. M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11;1(7898):72–73. doi: 10.1016/s0140-6736(75)91074-0. [DOI] [PubMed] [Google Scholar]
  10. Jordan J. A. Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):37–42. doi: 10.1016/s0002-9378(96)70370-8. [DOI] [PubMed] [Google Scholar]
  11. Kock W. C. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays. J Virol Methods. 1995 Sep;55(1):67–82. doi: 10.1016/0166-0934(95)00046-w. [DOI] [PubMed] [Google Scholar]
  12. Langnas A. N., Markin R. S., Cattral M. S., Naides S. J. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology. 1995 Dec;22(6):1661–1665. [PubMed] [Google Scholar]
  13. McOmish F., Yap P. L., Jordan A., Hart H., Cohen B. J., Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol. 1993 Feb;31(2):323–328. doi: 10.1128/jcm.31.2.323-328.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mortimer P. P., Luban N. L., Kelleher J. F., Cohen B. J. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet. 1983 Aug 27;2(8348):482–484. doi: 10.1016/s0140-6736(83)90512-3. [DOI] [PubMed] [Google Scholar]
  15. Nour B., Green M., Michaels M., Reyes J., Tzakis A., Gartner J. C., McLoughlin L., Starzl T. E. Parvovirus B19 infection in pediatric transplant patients. Transplantation. 1993 Oct;56(4):835–838. doi: 10.1097/00007890-199310000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981 Mar 21;1(8221):664–665. doi: 10.1016/s0140-6736(81)91579-8. [DOI] [PubMed] [Google Scholar]
  17. Phillips D. L., Keeffe E. B. Hematologic manifestations of gastrointestinal disease. Hematol Oncol Clin North Am. 1987 Jun;1(2):207–228. [PubMed] [Google Scholar]
  18. Reid D. M., Reid T. M., Brown T., Rennie J. A., Eastmond C. J. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet. 1985 Feb 23;1(8426):422–425. doi: 10.1016/s0140-6736(85)91146-8. [DOI] [PubMed] [Google Scholar]
  19. Winkler M., Schulze F., Jost U., Ringe B., Pichlmayr R. Anaemia associated with FK 506 immunosuppression. Lancet. 1993 Apr 17;341(8851):1035–1036. [PubMed] [Google Scholar]
  20. Zeldis J. B., Dienstag J. L., Gale R. P. Aplastic anemia and non-A, non-B hepatitis. Am J Med. 1983 Jan;74(1):64–68. doi: 10.1016/0002-9343(83)91119-1. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES